Arabian International Healthcare Holding Past Earnings Performance
Past criteria checks 3/6
Arabian International Healthcare Holding's earnings have been declining at an average annual rate of -32.7%, while the Healthcare industry saw earnings growing at 18.7% annually. Revenues have been declining at an average rate of 3.2% per year. Arabian International Healthcare Holding's return on equity is 11.8%, and it has net margins of 4.7%.
Key information
-32.7%
Earnings growth rate
-174.0%
EPS growth rate
Healthcare Industry Growth | 12.3% |
Revenue growth rate | -3.2% |
Return on equity | 11.8% |
Net Margin | 4.7% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For Arabian International Healthcare Holding (TADAWUL:9530)
Jul 19Here's What's Concerning About Arabian International Healthcare Holding's (TADAWUL:9530) Returns On Capital
Mar 22Calculating The Fair Value Of Arabian International Healthcare Holding Company (TADAWUL:9530)
Aug 30Revenue & Expenses Breakdown
How Arabian International Healthcare Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 807 | 38 | 143 | 0 |
30 Sep 23 | 775 | 28 | 131 | 0 |
30 Jun 23 | 743 | 24 | 117 | 0 |
31 Mar 23 | 693 | 25 | 113 | 0 |
31 Dec 22 | 643 | 20 | 110 | 0 |
30 Sep 22 | 614 | 39 | 96 | 0 |
30 Jun 22 | 585 | 57 | 83 | 0 |
31 Mar 22 | 602 | 69 | 78 | 0 |
31 Dec 21 | 619 | 82 | 73 | 0 |
30 Sep 21 | 746 | 107 | 86 | 0 |
30 Jun 21 | 874 | 132 | 98 | 0 |
31 Mar 21 | 846 | 114 | 99 | 0 |
31 Dec 20 | 819 | 96 | 100 | 0 |
31 Dec 19 | 697 | 41 | 110 | 0 |
Quality Earnings: 9530 has a large one-off gain of SAR28.1M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 9530's current net profit margins (4.7%) are higher than last year (3.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9530's earnings have declined by 32.7% per year over the past 5 years.
Accelerating Growth: 9530's earnings growth over the past year (86%) exceeds its 5-year average (-32.7% per year).
Earnings vs Industry: 9530 earnings growth over the past year (86%) exceeded the Healthcare industry 42.3%.
Return on Equity
High ROE: 9530's Return on Equity (11.8%) is considered low.